Cargando…
A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570496/ https://www.ncbi.nlm.nih.gov/pubmed/28837660 http://dx.doi.org/10.1371/journal.pone.0183929 |
_version_ | 1783259188739178496 |
---|---|
author | Van Goor, Angelica Stromberg, Zachary R. Mellata, Melha |
author_facet | Van Goor, Angelica Stromberg, Zachary R. Mellata, Melha |
author_sort | Van Goor, Angelica |
collection | PubMed |
description | Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment, condemnation of products, and death. In this study, we evaluated a recombinant antigens (rAg) vaccine combining common ExPEC surface proteins EtsC, OmpA, OmpT, and TraT for broad protective potential against APEC infections in chickens. The specific objectives were to evaluate antibody (serum) and cytokines (lymphoid organs) responses to vaccination; in vitro bactericidal ability of serum and splenocytes against multiple APEC serotypes; and in vivo protection against APEC challenge in chickens. Groups of four-day old chickens (N = 10) were vaccinated twice (two-week interval) subcutaneously with rAgs alone or in combination and CpG adjuvant or PBS (control). IgY antibody in the serum and mRNA expression of IL-1β, IL-6, IL-18, IFN-γ, IL-4, IFN-β, and IL-8 in bursa, spleen, and thymus were measured using ELISA and RT-qPCR, respectively. Serum and splenocytes were tested for their bactericidal ability in vitro against multiple APEC isolates. Vaccinated and non-vaccinated chickens were challenged with 10(8) CFU of APEC-O2 via air sac at 31 days post first vaccination. Vaccine protection was determined by the decrease of bacterial loads in blood and organs (lung, heart, spleen, and liver), as well as gross colibacillosis lesion scores in air sac, heart, and liver. Vaccination significantly (P < 0.05) elicited IgY against specific antigens, induced immune related mRNA expression in the spleen and bursa, reduced in vitro growth of multiple APEC serotypes, and decreased bacterial loads in the heart and spleen, and gross lesion scores of the air sac, heart and liver in chickens. The vaccine reported may be used to provide broad protection against APEC strains, increasing animal welfare and food production. |
format | Online Article Text |
id | pubmed-5570496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55704962017-09-09 A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli Van Goor, Angelica Stromberg, Zachary R. Mellata, Melha PLoS One Research Article Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment, condemnation of products, and death. In this study, we evaluated a recombinant antigens (rAg) vaccine combining common ExPEC surface proteins EtsC, OmpA, OmpT, and TraT for broad protective potential against APEC infections in chickens. The specific objectives were to evaluate antibody (serum) and cytokines (lymphoid organs) responses to vaccination; in vitro bactericidal ability of serum and splenocytes against multiple APEC serotypes; and in vivo protection against APEC challenge in chickens. Groups of four-day old chickens (N = 10) were vaccinated twice (two-week interval) subcutaneously with rAgs alone or in combination and CpG adjuvant or PBS (control). IgY antibody in the serum and mRNA expression of IL-1β, IL-6, IL-18, IFN-γ, IL-4, IFN-β, and IL-8 in bursa, spleen, and thymus were measured using ELISA and RT-qPCR, respectively. Serum and splenocytes were tested for their bactericidal ability in vitro against multiple APEC isolates. Vaccinated and non-vaccinated chickens were challenged with 10(8) CFU of APEC-O2 via air sac at 31 days post first vaccination. Vaccine protection was determined by the decrease of bacterial loads in blood and organs (lung, heart, spleen, and liver), as well as gross colibacillosis lesion scores in air sac, heart, and liver. Vaccination significantly (P < 0.05) elicited IgY against specific antigens, induced immune related mRNA expression in the spleen and bursa, reduced in vitro growth of multiple APEC serotypes, and decreased bacterial loads in the heart and spleen, and gross lesion scores of the air sac, heart and liver in chickens. The vaccine reported may be used to provide broad protection against APEC strains, increasing animal welfare and food production. Public Library of Science 2017-08-24 /pmc/articles/PMC5570496/ /pubmed/28837660 http://dx.doi.org/10.1371/journal.pone.0183929 Text en © 2017 Van Goor et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Van Goor, Angelica Stromberg, Zachary R. Mellata, Melha A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli |
title | A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli |
title_full | A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli |
title_fullStr | A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli |
title_full_unstemmed | A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli |
title_short | A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli |
title_sort | recombinant multi-antigen vaccine with broad protection potential against avian pathogenic escherichia coli |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570496/ https://www.ncbi.nlm.nih.gov/pubmed/28837660 http://dx.doi.org/10.1371/journal.pone.0183929 |
work_keys_str_mv | AT vangoorangelica arecombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli AT strombergzacharyr arecombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli AT mellatamelha arecombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli AT vangoorangelica recombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli AT strombergzacharyr recombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli AT mellatamelha recombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli |